Cholesterol metabolism modulation

Cholesterol metabolism modulation refers to the regulation and therapeutic targeting of the processes controlling cholesterol biosynthesis, uptake, transport, storage, and excretion within organisms. This is a complex, multi-enzyme and multi-pathway network, involving key molecular players such as HMG-CoA reductase (rate-limiting enzyme in biosynthesis), SREBP family transcription factors (sterol response element-binding proteins), LDL receptors, ABCA1 transporters, and a variety of regulatory molecules including hormones and microRNAs. Rather than being a single molecule or receptor, cholesterol metabolism modulation describes a therapeutic strategy or area of drug development focused on altering cholesterol levels, and is implicated in the prevention and treatment of major diseases like cardiovascular disease, atherosclerosis, NAFLD, and certain cancers. Individual molecular targets within this process (such as HMG-CoA reductase, SREBP2, etc.) are established drug targets, but "cholesterol metabolism modulation" itself is not a single target but a biological process or strategy. Therefore, it is not appropriate to use "cholesterol metabolism modulation" as the canonical name for a molecule/receptor target.

Other names

Cholesterol homeostasis modulationRegulation of cholesterol metabolismCholesterol metabolic process regulation

Inhibition of cholesterol biosynthesis enzymes (e.g., HMG-CoA reductase inhibition); Enhancement of cholesterol efflux (e.g., agonism of ABCA1 transporter/HDL formation); Blockage of cholesterol absorption (intestinal transporter inhibition); Promotion of LDL receptor expression (SREBP pathway modulation); Modulation of transcription factors (e.g., SREBPs, LXRs); Silencing or mimicking microRNAs that regulate cholesterol metabolism genes